Oxygen Therapy an anti-fungal?
The book "The Beneficent
Suspicions" had elicited many questions on the suspected target -- a
pathogenic microbe -- as the etiologic factor behind chronic diseases.
Current understanding of chronic diseases, to
Mycoalkonics, is missing the trees from the forest. Though admittedly
there is not enough study in the
pathological science in this direction (for reasons best known to them
and even for the suspected commercial reasons) we should not sit tight
and wait for the medical mainstream to tell us the facts.
fact that Hyperbaric Oxygen Treatment or Therapy (HBOT) does
actually bring astounding results to solve diabrenec
gangrenous wounds (which are adjunctive to diabetes) is another factual
evidence that lend credence to the suspicion or possibility
that a pathogen is involved. It is known that
microbes can be killed by oxygen therapy.
There are hospitals
around the world (mostly in the West) where HBOT is
provided; an example is at
La Grange Memorial Hospital where diabetic patients suffering
from traumatic and difficult to heal wounds, are given such treatments
thus circumventing the eventuality of limb amputation. Another example is given in an
advertisement in a periodical magazine (picture right).
With the high suspicion
on pathogenic fungi behind degenerative
diseases, HBOT holds promise as a potential
killer of pathogenic microbes including pathogenic fungi. However,
strangely, HBOT is
afflicted with limited research to expand its usage to address a wider
spectrum of degenerative ailments.
The main equipment of HBOT is a chamber for the patient(s) (an
individual or multiple individuals at a time) into which oxygen is
pumped at below sea-level pressure, say at about 10-30 below sea-level
pressure. This equipment was invented some 350 years ago and during the
1930s it was used to treat divers experiencing diving disorders and
also to normalize the body back to sea-level pressure.
One thing to note from HBOT is it has been used successfully to treat
in diabetic patients where antibiotics and
debridement fail miserably. There is an approved list of indications
which HBOT can be administered and is governed by the Hyperbaric Oxygen
In that list of indications, there are two conditions which are similar
to peripheral vascular diseases (PVD):
Clostridial Myositis and Myonecrosis (Gas Gangrene)
condition where the Clostridium bacterium infects a wound and its
metabolate (hydrogen sulphide gas molecules) seep into the surrounding
tissues thus contributing to the 'purplish' hue. Some diabetic patients
present this indication.
Necrotizing Soft Tissue Infections
-- a condition where
the human flesh, for example in the extremities of the body (fingers,
toes, ear lobes, mouth, eye, etc) waste away for certain reasons or
otherwise are secondary effects of radiation therapy in soft tissue
Many wonder why HBOT is still not pursued or studied to be used for
other diabetes-related complications such as diabetic neuropathy and
other degenerative diseases for that matter. HBOT holds promise as an
adjunctive treatment for degenerative diseases since there are solid
data indicative of pathogenic fungi as the prime agent behind most
The contention that oxygen will aggravate the angiogenesis2
condition for cancer cells (which would not be favorable because cancer
will gain more access to oxygen supply from the body) has not been
shown to be true. If fungi cells are actually behind degenerative
diseases and cancer, angiogenesis will actually work against neoplastic
conditions. There are more benefits to be had from skilful and
expedient use of HBOT to bring more hope to many 'hopeless' or
'incurable' conditions. There has been success in using HBOT for
'off-label' treatments such as diabetes, strokes, and cancers.
HBOT originated from a specialized field of medical practice which
caters to alleviating the human disorders which arise from compression
and decompression in external pressure on the human physical body and
brain, for example as experienced by deep sea divers, deep underground
miners, and working at high altitudes. This specialized treatment has
been introduced since the 1930s.